Antithrombotic medications in dialysis patients: a double-edged sword.

about

The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

P2860

Q58792844-AAB4AD1F-7A8E-4722-A4CA-5AEC4F346653

P2860

Antithrombotic medications in dialysis patients: a double-edged sword.

Item

http://www.wikidata.org/entity/Q38918821

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Antithrombotic medications in dialysis patients: a double-edged sword.

@en

type

Item

label

Antithrombotic medications in dialysis patients: a double-edged sword.

@en

prefLabel

Antithrombotic medications in dialysis patients: a double-edged sword.

@en

P1476

Antithrombotic medications in dialysis patients: a double-edged sword

@en

P2093

Farid Girgis Ghalli

http://www.w3.org/2001/XMLSchema#string

P2860

Contaminated heparin associated with adverse clinical events and activation of the contact system

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis

Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters

Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis

Thrombosis in end-stage renal disease.

Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.

Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.

Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

P304

53-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JEBM.12235

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Georgios Vlachopanos

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28276631

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

Antithrombotic medications in dialysis patients: a double-edged sword.

about

P2860

P2860

Antithrombotic medications in dialysis patients: a double-edged sword.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921